Retrive Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-05-2024
- Paid Up Capital ₹ 0.10 M
as on 16-05-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -70.29%
(FY 2023)
- Profit 57.00%
(FY 2023)
- Ebitda 59.17%
(FY 2023)
- Net Worth 45.49%
(FY 2023)
- Total Assets 50.92%
(FY 2023)
About Retrive Pharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kuldeep Patel, Kishorbhai Transadiya, and Nirmal Patel serve as directors at the Company.
- CIN/LLPIN
U24290GJ2019PTC110939
- Company No.
110939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2019
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Retrive Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuldeep Patel  | Director | 21-Nov-2019 | Current |
| Kishorbhai Transadiya | Director | 21-Nov-2019 | Current |
| Nirmal Patel | Director | 21-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Retrive Pharma.
Retrive Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 70.29% decrease. The company also saw a substantial improvement in profitability, with a 57% increase in profit. The company's net worth Soared by an impressive increase of 45.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Retrive Pharma?
Unlock access to Retrive Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vetlife Animalhealth Private Limited
Active 6 years 10 monthsKuldeep Patel and Kishorbhai Transadiya are mutual person
Acm Property Management Private Limited
Active 2 years 6 monthsKishorbhai Transadiya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Retrive Pharma?
Unlock and access historical data on people associated with Retrive Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Retrive Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Retrive Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
